Tharimmune, Inc. (THAR)
2.96
-0.10
(-3.27%)
USD |
NASDAQ |
Jan 15, 16:00
2.99
+0.03
(+1.01%)
Pre-Market: 08:54
Tharimmune SG&A Expense (TTM): 6.835M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Phio Pharmaceuticals Corp. | 4.234M |
| ETHZilla Corp. | 229.01M |
| Flora Growth Corp. | 2.383M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |
| Palatin Technologies, Inc. | 7.449M |